John Vavricka's Net Worth

$120 Thousand

Estimate Recalculated Nov 1, 2024 09:21AM EST

Who is John Vavricka?

John Vavricka does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Atea Pharmaceuticals, Inc..

SEC CIK

John Vavricka's CIK is 0001829630

Past Insider Trading and Trends

2023 was John Vavricka's most active year for acquiring shares with 2 total transactions. John Vavricka's most active month to acquire stocks was the month of December. 2024 was John Vavricka's most active year for disposing of shares, totalling 2 transactions. John Vavricka's most active month to dispose stocks was the month of December. 2023 saw John Vavricka paying a total of $0.00 for 240,000 shares, this is the most they've acquired in one year. In 2024 John Vavricka cashed out on 45,153 shares for a total of $45,420.42, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Atea Pharmaceuticals, Inc. (AVIR) Snapshot price: $3.47

Chief Commercial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
21.52K
$3.84
-$45,420.42
21.52K
Jan 31 - Feb 1
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
Jan 29
Form 4
∞
82.51K
—
—
82.51K
Nov 3
Form 3
—
0
—
—
0
No matching records found